Literature DB >> 18402295

Seroprevalence of tetanus antibody in the Thai population: a national survey.

Pantipa Chatchatee1, Susheera Chatproedprai, Porpit Warinsathien, Piyanit Tharmaphornpilas, Pornsak Yoocharoen, Sirisak Warintrawat, Apiradee Theamboonlers, Voranush Chongsrisawat, Yong Poovorawan.   

Abstract

Tetanus is a disease with high mortality and the most important measure for effective prevention is vaccination. Tetanus immunization has been introduced to Thailand's national immunization program for 30 years. Yet, the coverage and seroprevalence of tetanus antibody in vast parts of the population has not been assessed. This study has been performed on 1,277 subjects aged between 6 months and 60 years or above from four geographically distinct provinces of Thailand. Tetanus antibody levels were measured using a commercially available ELISA kit. Most of the Thai population had immunity against tetanus. The level of antibodies to tetanus, as demonstrated by the geometric mean titer of antibody (GMT) (and 95% confidence interval) was 2.62 (2.34-2.91) IU/ml. The highest and lowest GMT was found in subjects aged between 5 and 9 years, and above 60 years of age with GMT (and 95% confidence intervals) of 3.64 (3.34-3.96) and 1.24 (0.67-2.29) IU/ml respectively. The minimum protective level of antitoxin (>0.01 IU/ml) was detected in 99.7 % of subjects. More than 90% of subjects displayed durable antibody protection levels (DAPL) (> or = 1.0 IU/ml), except for subjects above the age of 60 years (82%). According to this study, the majority of the population expresses tetanus antibody levels that can confer long term protection. Yet, considering the lowest GMT and the highest incidence of tetanus cases found in subjects aged above 60 years, re-immunization should be targeted at this age group especially if they had sustained any tetanus-prone injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18402295

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  5 in total

1.  Acupuncture-Associated Mycobacterium massiliense and Scedosporium Infections Superimposed by Tetanus.

Authors:  Thaninee Prasoppokakorn
Journal:  Case Rep Infect Dis       Date:  2022-07-07

2.  Seroepidemiology of tetanus in Hangzhou from 2009 to 2018.

Authors:  Yuyang Xu; Yan Liu; Jian Du; Wei Zheng; Shijun Liu; Xuechao Zhang; Xiaoping Zhang; Jun Wang; Xinren Che; Wenwen Gu; Wei Jiang
Journal:  Hum Vaccin Immunother       Date:  2020-05-27       Impact factor: 3.452

3.  Tetanus vaccination, antibody persistence and decennial booster: a serosurvey of university students and at-risk workers.

Authors:  M Borella-Venturini; C Frasson; F Paluan; D DE Nuzzo; G DI Masi; M Giraldo; F Chiara; A Trevisan
Journal:  Epidemiol Infect       Date:  2017-03-15       Impact factor: 4.434

4.  Immunity to tetanus in major beta thalassemia patients.

Authors:  Abdolreza Sotoodeh Jahromi; Karamatollah Rahmanian
Journal:  Clin Exp Vaccine Res       Date:  2015-07-29

5.  Seroprevalence of an antibody against diphtheria, tetanus, and pertussis among the elderly in Khon Kaen, Thailand.

Authors:  Teeraporn Chinchai; Nawarat Posuwan; Viboonsak Vuthitanachot; Nasamon Wanlapakorn; Yong Poovorawan
Journal:  J Health Popul Nutr       Date:  2019-10-18       Impact factor: 2.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.